Choking
Also known as: Aspiration, Aspirated, Aspirating, Choked
Methodology & AI Transparency ⓘ
Choking Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Food or small objects can cause choking if they get caught in your throat and block your airway.
- 2 Real-world patient consensus: Clinical coding for Choking uses ICD-10 R09.89 across ENT & Hearing specialty care.
- 3 Typical cash cost range: Differential triage of Choking (R09.89) utilizes preventive periodontal debridement [Choking R09.89].
- 4 Top reported side effects / signs: Longitudinal Choking monitoring tracks Periodontal Pocket Depth in Choking (R09.89: & Bleeding Index) toward Probing <= 3 mm without bleeding (R09.89).
Ask our AI Specialists anything about Choking
What Is Choking?
Food or small objects can cause choking if they get caught in your throat and block your airway. This keeps oxygen from getting to your lungs and brain. If your brain goes without oxygen for more than four minutes, you could have brain damage or die. Young children are at an especially high risk of choking. They can choke on foods like hot dogs, nuts and grapes, and on small objects like toy pieces and coins. Keep hazards out of their reach and supervise them when they eat. When someone is choking, quick action can be lifesaving. Learn how to do back blows, the Heimlich maneuver (abdominal thrusts), and CPR .
Pathophysiology, Underlying Causes & Clinical Presentation
In Choking (R09.89), physiological disruption stems from or subgingival bacterial in Choking (R09.89: biofilm triggering periodontal), Cross-referenced with NIH MeSH (Airway Obstruction), informing Ear, Nose, Throat & Oral Health protocols that track Pure-Tone Audiometry & in Choking (R09.89: Tympanometry) (Thresholds <= 20 dB HL; normal middle-ear pressure (R09.89)).
Common Symptoms & Clinical Signs
- • Presentation of Choking (R09.89): bleeding or receding in Choking (R09.89: gums, tooth sensitivity,)
- • Secondary Choking clinical sign: muffled hearing, ear in Choking (R09.89: fullness, popping pressure,)
- • Symptom flares in Choking correlating with Periodontal Pocket Depth in Choking (R09.89: & Bleeding Index) deviation outside Probing <= 3 mm without bleeding (R09.89)
- • Functional ent & hearing impact requiring preventive periodontal debridement [Choking R09.89] evaluation (R09.89)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Choking Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R09.89 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Ear, Nose, Throat & Oral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Periodontal Pocket Depth in Choking (R09.89: & Bleeding Index) | Probing <= 3 mm without bleeding (R09.89) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pure-Tone Audiometry & in Choking (R09.89: Tympanometry) | Thresholds <= 20 dB HL; normal middle-ear pressure (R09.89) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Choking
Treatment selection for Choking depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Choking)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Year two assessment of fenofibric acid and moderate-dose statin combination: a This long-term study demonstrated that fenofibric acid + moderate-dose statin was generally well tolerated with no new or unexpected safety concerns, and resulted in comprehensive and sustained lipid improvements in patients... Clinical drug investigation • 2010-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 19995098 ↗ |
| Can This Approach Help? Inside the Latest Research on Endothelial Glycocalyx Degradation in Sepsis: Analysis of the Crystalloid Liberal Fluid resuscitation strategy had no impact on endothelial glycocalyx degradation, and there was no evidence for a differential effect of resuscitation strategy by baseline levels of endothelial glycocalyx degradation. Annals of the American Thoracic Society • 2025-09-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 40315385 ↗ |
| Can This Approach Help? Inside the Latest Research on A Phase II/III multicenter randomized single blind non-inferiority immunogenicity The study results indicate that the TeddyVac ™ vaccine is immunogenic, safe and non-inferior to the comparator Vaccine when administered to healthy subjects of 10 to 60 years of age. Infectious diseases (London, England) • 2025-03-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 39378070 ↗ |
| Managing GHD: Can Effective GH Replacement With Somapacitan Make a Real Difference? (What New Research Reveals) Somapacitan in children with GHD showed sustained efficacy and tolerability for 2 years, and after switching from daily GH. The Journal of clinical endocrinology and metabolism • 2023-11-17 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 37406251 ↗ |
Choking Patient Community & “People Like Me” Threads
Filter Choking community threads and patient logs by age, biological sex, dosage, and treatment duration.